Clinical Data from Assembly Biosciences’ HBV Core Inhibitors Presented at The Digital International Liver CongressTM EASL 2020

NEXT STORY
Global Molecular Diagnostics Industry Analysis (2020-2025) and the Impact of COVID-19
PREV STORY
Tiziana Life Sciences Clarifies Reason for Filing an Amended ADS Registration Statement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

China National Drug Administration grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer

Approval follows priority review of Alecensa in China, just eight and nine months after ...

author_avatar
NASDAQ Market News

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2016 Financial Results

DUBLIN, Ireland, July 14, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading ...

author_avatar
NASDAQ Market News

Oasmia completes a private placement of new convertible instruments in the amount SEK 35.2 million

Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) hereby announces that the Company has ...

author_avatar
NASDAQ Market News